Search results
Showing results for
Oxford University doctors and scientists are performing the second phase of clinical studies of an experimental Ebola vaccine regimen. The study is part of the EBOVAC2 project, a collaborative programme involving the University of Oxford, French Institute of Health and Medical Research (INSERM) as project coordinator, London School of Hygiene & Tropical Medicine, Le Centre Muraz, Inserm Transfert (IT) and the Janssen Pharmaceutical Companies of Johnson & Johnson.
Severe anaemia and invasive bacterial infections in Kenyan children: a 26-year hospital surveillance observational study.
Journal article
Abuga KM. et al, (2027), Lancet Glob Health
Developing a global framework to assess a country's readiness and resilience to introduce a new vaccine or improve uptake of an underutilized vaccine.
Journal article
Monk V. et al, (2026), Expert Rev Vaccines, 25
The CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19.
Journal article
Kazungu Y. et al, (2026), Virulence, 17
Parental motivations, facilitators, and barriers to participating in a pediatric vaccine trial in Kathmandu, Nepal: A qualitative study.
Journal article
Firth C. et al, (2026), Hum Vaccin Immunother, 22
What is unhealthy about public health? Vaccination, evidence and the politics of uncertainty
Journal article
Mezza M. and Vanderslott S., (2026), Humanities and Social Sciences Communications, 13
Accurately modeling RNase H-mediated antisense oligonucleotide efficacy
Journal article
Hill B. et al, (2026), Molecular Therapy Nucleic Acids, 37
TTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMT.
Journal article
Prunotto G. et al, (2026), J Hum Immun, 2
Timing matters: Exon skipping therapy is most effective when initiated early in a mouse model of Duchenne muscular dystrophy
Journal article
Stenler S. et al, (2026), Molecular Therapy Nucleic Acids, 37, 103017 - 103017
Muscle MRI as an Imaging Biomarker of Muscle Damage in Patients With Spinal and Bulbar Muscular Atrophy.
Journal article
Grunseich C. et al, (2026), Neurology, 107
COVID-19 vaccine effectiveness and SARS-CoV-2 variants in Nepal: Test-negative case-control study and genetic sequencing (COVVAR Nepal)
Journal article
Pokhrel B. et al, (2026), Vaccine X, 31
The Thrombopoietin Receptor S264F Mutant Drives MPN with Marrow Fibrosis Through a Dual Mechanism
Journal article
MEAD A., (2026), HemaSphere
Typhoid Seroepidemiology for TCV Decision‑Making Meeting Report of the 18 July 2025 Expert Consultation
Preprint
Laurens M. et al, (2026)
The effect of cohesin mutations on HLA-class II expression in the myeloid leukemia of Down syndrome.
Journal article
Boucher AC. et al, (2026), Leukemia
ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.
Journal article
Ebrahimi N. et al, (2026), Vaccine, 88
Genome-wide association study of susceptibility to pneumococcal carriage amongst children
Preprint
Kandasamy R. et al, (2026)
Conference report: airway mucosal sampling and immune analysis.
Journal article
Rosenheim J. et al, (2026), Vaccine, 88
Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, Bangladesh.
Journal article
Khanam F. et al, (2026), Clin Infect Dis
Genomic Epidemiology of Multi-Modal ESBL Gene Transmission among Enterobacterales in a Neonatal Unit
Preprint
Parker MJ. et al, (2026)